🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or administering at home.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially significant medical dangers”.